Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Pharma
Argenx builds clinical case for 'pipeline in a product' efgart
As efgartigimod gains traction in myasthenia gravis, argenx is out to prove its antibody fragment is no one-hit wonder.
Fraiser Kansteiner
Dec 10, 2022 11:30am
Pfizer tops autoimmune patients' reputation list in 2021: report
Nov 7, 2022 9:35am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
Illuminated blue buildings bring attention to alopecia areata
Sep 7, 2022 7:40am
Novartis' Sandoz boosts biosimilars awareness with new campaign
Jun 1, 2022 3:53pm
Calliditas launches IgA kidney disease education campaign
May 20, 2022 9:35am